“We consulted with our membership and the majority recommended that we hold the Congress again in 2021 as a purely virtual event. Some of our member companies have still not allowed in person attendance at conferences. Barring unexpected developments, we are currently planning to return to the hybrid model in 2022 which will offer registrants to option of participation onsite or online.”
— PCF Executive Committee
CO CHAIRS
Indrani Franchini, JD
Executive Vice President Chief Compliance Officer, Alexion Pharmaceuticals, New York, NY
Joshua Marks, JD
Vice President, Chief Ethics & Compliance Officer, Boehringer Ingelheim; Former Executive Division Counsel, Corporate Compliance Officer & Asst. Secretary, Ben Venue Laboratories; Ridgefield, CT
Margaret Sparks, JD
Head of Compliance, Vaccines, North America Ethics and Business Integrity, Sanofi, Bridgewater, NJ
Ann-Marie Tejcek, MA
Senior Director, Chief Compliance Officer North America, Eli Lilly, Indianapolis, IN
Donna White, CCEP
Vice President, Compliance, Chiesi, USA
Cary, NC
Joe Zimmerman
Vice President, Chief Compliance Officer & Privacy Officer, Ferring Pharmaceuticals, Inc., Parsippany, NJ
FEATURING THE PCF PHARMA CONGRESS ADVANCED VIRTUAL INTERACTIVE VIDEO BROADCAST PORTAL
Featuring one-on-one attendee video chat and large group video interactive workshops.
See last year’s Congress portal:
